Tissue Engineering Market Overview
Tissue engineering (TE) is a fast-growing field that aims to repair, replace, or regenerate tissues and organs by translating fundamental physics, chemistry, and biology knowledge into practical materials, technologies, and clinical techniques. The global Tissue Engineering Market is expected to rise at a significant rate in the estimated period.
Tissue engineering treatments' potential for curing irreversible tissue damage has boosted the market growth. Furthermore, an increase in demand for regenerative medicine and tissue engineering treatments to heal damaged tissues has aided this expansion. Tissue engineering offers an alternative to surgical reconstruction, transplants, and other mechanical devices for tissue healing. The market for tissue engineering is also propelled by a growing demand for effective regeneration treatments as the prevalence of diabetes, obesity, and other illnesses rises as a result of lifestyle changes, an ageing population, and an increase in the number of trauma cases.
The use of 3D bioprinters to efficiently design in vitro implants, as well as technological advancements in the field of 3D tissue engineering’s, such as the replacement of embryo cells with stem cells, organ-on-a-chip technology, and the use of 3D bioprinters to efficiently design in vitro implants, are expected to boost growth. Furthermore, an increase in government funding for medical and academic research activities will boost tissue engineering market growth over the projection period.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Application, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Medtronic plc, Zimmer Biomet Holdings, Inc, Allergan plc, Athersys, Inc, ACell, Inc., Organogenesis Holdings Inc, Tissue Regenix Group plc, Stryker Corporation, RTI Surgical, Inc., Integra LifeSciences Corporation, ReproCell, Inc., Baxter International, Inc. |
Covid-19 Impact on Tissue Engineering Market
In addition, the current Tissue Engineering Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Tissue Engineering Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Tissue Engineering Market Segment Overview
Based on Application, Orthopedics, Musculoskeletal, And Spine segment holds the largest share in the global tissue engineering market. This is due to an increase in the occurrence of musculoskeletal disorders. In addition, the orthopedic regenerative segment includes the spine, bone substitutes, and bone grafts. Moreover, Cardiology and Vascular is the major segments in the global tissue engineering market. This is due to a rapid rise in the incidence of cardiovascular disorders worldwide.
Tissue Engineering Market, By Application
· Cord blood & Cell Banking
· Cancer
· GI, Gynecology
· Dental
· Skin & Integumentary
· Urology
· Orthopedics, Musculoskeletal, & Spine
· Neurology
· Cardiology & Vascular
· Others
Tissue Engineering Market Regional Overview
In terms of region, North America commanded a major share, in terms of revenue, and is predictable to maintain its supremacy over the forecast period. This is attributable to an increasing geriatric population and increased awareness about stem cell therapy. Furthermore, better technology for the detection and treatment of chronic illnesses, the availability of private and government funding, and high healthcare spending all contribute to tissue engineering gaining a larger share of the regional market. Moreover, the market in the Asia Pacific is projected to rise significantly. Japan is one of the leading countries to foster technological advances in the tissue engineering field. Furthermore, an increase in the prevalence of clinical illnesses, such as cancer, in Asia is likely to propel the expansion of the tissue engineering market in the area. Market growth is also driven by factors such as the evolution of 3D bioprinting and medical tourism in the region.
Tissue Engineering Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Tissue Engineering Market, Key Players
· Medtronic plc
· Zimmer Biomet Holdings, Inc
· Allergan plc
· Athersys, Inc
· ACell, Inc.
· Organogenesis Holdings Inc
· Tissue Regenix Group plc
· Stryker Corporation
· RTI Surgical, Inc.
· Integra LifeSciences Corporation
· ReproCell, Inc.
· Baxter International, Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Tissue Engineering market?
Tissue engineering treatments' potential for curing irreversible tissue damage has boosted the market growth.
Q2. Which Segments are covered in the global Tissue Engineering market report?
Application, and Region. these segments are covered in the global Tissue Engineering market report.
Q3. Which segment is projected to hold the largest share in the global Tissue Engineering market?
Orthopedics, Musculoskeletal, and Spine segments is projected to hold the largest share in the global Tissue Engineering market.
Q4. Which region holds the largest share in the global Tissue Engineering market?
North America held the largest share in the global Tissue Engineering market.
Q5. Which are the prominent players in the global Tissue Engineering market?
Medtronic plc, Zimmer Biomet Holdings, Inc, Allergan plc, Athersys, Inc, ACell, Inc., Organogenesis Holdings Inc, Tissue Regenix Group plc, Stryker Corporation, RTI Surgical, Inc., Integra LifeSciences Corporation, ReproCell, Inc., Baxter International, Inc. are some key players in the global Tissue Engineering market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Tissue Engineering Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Cord blood & Cell Banking
- 5.2.2. Cancer
- 5.2.3. GI, Gynecology
- 5.2.4. Dental
- 5.2.5. Skin & Integumentary
- 5.2.6. Urology
- 5.2.7. Orthopedics, Musculoskeletal, & Spine
- 5.2.8. Neurology
- 5.2.9. Cardiology & Vascular
- 5.2.10. Others
- 5.3. Market Analysis, Insights and Forecast – By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America, Middle East and Africa
6. North America Tissue Engineering Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Cord blood & Cell Banking
- 6.2.2. Cancer
- 6.2.3. GI, Gynecology
- 6.2.4. Dental
- 6.2.5. Skin & Integumentary
- 6.2.6. Urology
- 6.2.7. Orthopedics, Musculoskeletal, & Spine
- 6.2.8. Neurology
- 6.2.9. Cardiology & Vascular
- 6.2.10. Others
- 6.3. Market Analysis, Insights and Forecast – By Country
- 6.3.1. U.S.
- 6.3.2. Canada
7. Europe Tissue Engineering Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Cord blood & Cell Banking
- 7.2.2. Cancer
- 7.2.3. GI, Gynecology
- 7.2.4. Dental
- 7.2.5. Skin & Integumentary
- 7.2.6. Urology
- 7.2.7. Orthopedics, Musculoskeletal, & Spine
- 7.2.8. Neurology
- 7.2.9. Cardiology & Vascular
- 7.2.10. Others
- 7.3. Market Analysis, Insights and Forecast – By Country
- 7.3.1. UK
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Rest of Europe
8. Asia Pacific Tissue Engineering Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Cord blood & Cell Banking
- 8.2.2. Cancer
- 8.2.3. GI, Gynecology
- 8.2.4. Dental
- 8.2.5. Skin & Integumentary
- 8.2.6. Urology
- 8.2.7. Orthopedics, Musculoskeletal, & Spine
- 8.2.8. Neurology
- 8.2.9. Cardiology & Vascular
- 8.2.10. Others
- 8.3. Market Analysis, Insights and Forecast – By Country
- 8.3.1. China
- 8.3.2. India
- 8.3.3. Japan
- 8.3.4. Australia
- 8.3.5. South East Asia
- 8.3.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Tissue Engineering Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Cord blood & Cell Banking
- 9.2.2. Cancer
- 9.2.3. GI, Gynecology
- 9.2.4. Dental
- 9.2.5. Skin & Integumentary
- 9.2.6. Urology
- 9.2.7. Orthopedics, Musculoskeletal, & Spine
- 9.2.8. Neurology
- 9.2.9. Cardiology & Vascular
- 9.2.10. Others
- 9.3. Market Analysis, Insights and Forecast – By Country
- 9.3.1. Brazil
- 9.3.2. Saudi Arabia
- 9.3.3. UAE
- 9.3.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Medtronic plc
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Zimmer Biomet Holdings, Inc
- 10.6. Allergan plc
- 10.7. Athersys, Inc
- 10.8. ACell, Inc.
- 10.9. Organogenesis Holdings Inc
- 10.10. Tissue Regenix Group plc
- 10.11. Stryker Corporation
- 10.12. RTI Surgical, Inc.
- 10.13. Integra LifeSciences Corporation
- 10.14. ReproCell, Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
